A Study of mRNA-1647 Cytomegalovirus Vaccine in Liver Transplant Candidates and Recipients

NCT06133010 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Trial was cancelled by Sponsor

Conditions

Cytomegalovirus Infection

Interventions

BIOLOGICAL: mRNA-1647
BIOLOGICAL: Placebo

Sponsor

ModernaTX, Inc.